ChemicalBook > CAS DataBase List > MFCD00167693

MFCD00167693

Product Name
MFCD00167693
CAS No.
199735-88-1
Chemical Name
MFCD00167693
Synonyms
HY-107999;MFCD00167693;CADD522 ,S0790;CADD522, 10 mM in DMSO;3-(N-(3,4-DICHLOROPHENYL)CARBAMOYL)-5-NORBORNENE-2-CARBOXYLIC ACID;3-[(3,4-dichlorophenyl)carbamoyl]bicyclo[2.2.1]hept-5-ene-2-carboxylic acid;3-{[(3,4-dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid;Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-[[(3,4-dichlorophenyl)amino]carbonyl]-;inhibit,MDA-231,Inhibitor,Reactive Oxygen Species,CADD 522,MCF7,MDA-468,breast cancer,CADD522,T47D-RUNX2,CADD-522
CBNumber
CB63058321
Molecular Formula
C15H13Cl2NO3
Formula Weight
326.17
MOL File
199735-88-1.mol
More
Less

MFCD00167693 Property

Boiling point:
569.1±50.0 °C(Predicted)
Density 
1.529±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO:157.5(Max Conc. mg/mL);482.87(Max Conc. mM)
Ethanol:65.0(Max Conc. mg/mL);199.28(Max Conc. mM)
form 
A solid
pka
4.19±0.40(Predicted)
color 
White to off-white
InChI
1S/C15H13Cl2NO3/c16-10-4-3-9(6-11(10)17)18-14(19)12-7-1-2-8(5-7)13(12)15(20)21/h1-4,6-8,12-13H,5H2,(H,18,19)(H,20,21)
InChIKey
YSDNWNOGHQYWPK-UHFFFAOYSA-N
SMILES
O=C(C1C2C=CC(C1C(NC3=CC=C(C(Cl)=C3)Cl)=O)C2)O
More
Less

Safety

WGK Germany 
WGK 3
Storage Class
11 - Combustible Solids
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
S720224
Product name
3-(N-(3,4-DICHLOROPHENYL)CARBAMOYL)-5-NORBORNENE-2-CARBOXYLIC ACID
Purity
AldrichCPR
Packaging
50MG
Price
$113
Updated
2025/07/31
Matrix Scientific
Product number
159610
Product name
3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
Packaging
0.500g
Price
$120
Updated
2021/12/16
Biosynth Carbosynth
Product number
FD136060
Product name
3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
Packaging
1g
Price
$128
Updated
2021/12/16
Biosynth Carbosynth
Product number
FD136060
Product name
3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
Packaging
500mg
Price
$75
Updated
2021/12/16
Matrix Scientific
Product number
159610
Product name
3-{[(3,4-Dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
Packaging
1g
Price
$150
Updated
2021/12/16
More
Less

MFCD00167693 Chemical Properties,Usage,Production

Uses

CADD522 is a potent inhibitor of RUNX2(runt-related transcription factor-2)-DNA.

Biological Activity

CADD522 is a cell-permeable, bioavailable, non-toxic carbamoyl-bicycloheptene-carboxylate th at inhibits RUNX2-DNA binding, thereby increases RUNX2 stability, upregulates RUNX2 expression levels and downregulates RUNX2 responsive genes transcription. CADD522 inhibits mitochondrial oxidative phosphorylation by decreasing the mitochondrial oxygen consumption rate and ATP production in human breast cancer cells in a RUNX2-independent manner. CADD-522 suppresses in vivo tumor growth and metastasis, and appreciably prolongs the survival rates without the need for surgery or chemotherapy.

in vivo

CADD522 (1, 5 and 20 mg/kg; i.p.; twice a week for 45 days) delays the onset of the tumors and suppresses tumor growth in mice[1].
CADD522 (10 mg/kg; i.p.; twice a week for 11 days) suppresses tumor metastasis and inhibits expression of Ki-67 in mice[1].

Animal Model:Female mice (6-week-old; MMTV-PyMT transgenic model)[1].
Dosage:1, 5 and 20 mg/kg
Administration:Intraperitoneal injection; twice a week for 45 days.
Result:Delayed the onset of the tumors, delayed tumor development and reduced tumor burden in transgenic MMTV-PyMT mice.
Reduced the tumor weight in mice.
Animal Model:Female NOD scid gamma (NSG) mice and nude mice (TNBC-PDX Br-001 model)[1].
Dosage:10 mg/kg
Administration:Intraperitoneal injection; twice a week for 11 days.
Result:Significant decreased tumor volume and markedly inhibited expression of Ki-67.
Inhibited experimental metastasis of BC cells in vivo.(did not significantly decrease body weight or influence the general health of animals).

IC 50

RUNX2: 10 nM ()

MFCD00167693 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

MFCD00167693 Suppliers

BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
12952
Advantage
65
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Tianjin Kailiqi Biotechnology Co., Ltd.
Tel
15076683720
Fax
022-23754520
Email
klq@cw-bio.com
Country
China
ProdList
9431
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Shanghai Rechem science Co., Ltd.
Tel
021-31433387 15618786686
Fax
QQ:1369748377
Email
sales@rechemscience.com
Country
China
ProdList
2961
Advantage
58
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 18101056239
Email
3193328036@qq.com
Country
China
ProdList
29662
Advantage
68
MQ (shanghai) Pharmaceuticals Co., Ltd.
Tel
13761635123
Fax
1014988033@qq
Email
sales@linyuepharm.com
Country
China
ProdList
5229
Advantage
55
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32470
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58

199735-88-1, MFCD00167693Related Search:


  • MFCD00167693
  • 3-{[(3,4-dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
  • HY-107999
  • Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-[[(3,4-dichlorophenyl)amino]carbonyl]-
  • inhibit,MDA-231,Inhibitor,Reactive Oxygen Species,CADD 522,MCF7,MDA-468,breast cancer,CADD522,T47D-RUNX2,CADD-522
  • 3-[(3,4-dichlorophenyl)carbamoyl]bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
  • CADD522, 10 mM in DMSO
  • 3-(N-(3,4-DICHLOROPHENYL)CARBAMOYL)-5-NORBORNENE-2-CARBOXYLIC ACID
  • CADD522 ,S0790
  • 199735-88-1